X. Latypova
Physiology · 2011
A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 13 citations into it
- Cellular and Molecular Neuroscience — 5 citations into it
Whom X. Latypova trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from X. Latypova's perspective
Ordered by how strongly the researchers X. Latypova trusts endorse each paper. Same corpus, a different order for every researcher.
- A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. (Nature Chemical Biology)
- O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. (Proceedings of the National Academy of Sciences of the United States of America)
- Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease (Proceedings of the National Academy of Sciences of the United States of America)
- Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. (Brain research. Brain research reviews)
- Tau is essential to β-amyloid-induced neurotoxicity (Proceedings of the National Academy of Sciences of the United States of America)
- The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. (Journal of Clinical Investigation)
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. (Trends in Molecular Medicine)
- CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function (Science)
- Neuropathological stageing of Alzheimer-related changes
Their papers
- Post-translational modifications of tau protein: implications for Alzheimer's disease. (2011) — 610 citations